These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6934559)

  • 41. Plasma norepinephrine and epinephrine levels in essential hypertension.
    Goldstein DS; Lake CR
    Fed Proc; 1984 Jan; 43(1):57-61. PubMed ID: 6690339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The time course of brain and blood catecholamines, catechol O-methyltransferase, and amino acids in rats convulsed by oxygen at high pressure.
    Banister EW; Singh AK
    Can J Physiol Pharmacol; 1979 Apr; 57(4):390-5. PubMed ID: 455139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of human erythrocyte and gastroduodenal catechol-O-methyltransferase activity by nitecapone.
    Schultz E; Tarpila S; Bäckström AC; Gordin A; Nissinen E; Pohto P
    Eur J Clin Pharmacol; 1991; 40(6):577-80. PubMed ID: 1884738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Catechol-O-methyltransferase activity in red blood cells in threatened preterm labor; effect of indomethacin and nylidrin.
    Kurki T; Schultz E; Lindén IB; Ylikorkala O
    Acta Obstet Gynecol Scand; 1991; 70(3):187-91. PubMed ID: 1927294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Erythrocytes catechol-O-methyltransferase activity and indices of sympathetic activity in man.
    Fitzgerald GA; Hamilton CA; Jones DH; Reid JL
    Clin Sci (Lond); 1980 May; 58(5):423-5. PubMed ID: 7190087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Catecholamines block the antimitogenic effect of estradiol on human glomerular mesangial cells.
    Dubey RK; Zacharia LC; Gillespie DG; Imthurn B; Jackson EK
    Hypertension; 2003 Sep; 42(3):349-55. PubMed ID: 12913061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma free and sulfate conjugated catecholamine levels during acute physiological stimulation in man.
    Joyce DA; Beilin LJ; Vandongen R; Davidson L
    Life Sci; 1982 Feb; 30(5):447-54. PubMed ID: 6895925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A sensitive radioenzymatic assay for dopamine, norepinephrine, and epinephrine in plasma and tissue.
    Ben-Jonathan N; Porter JC
    Endocrinology; 1976 Jun; 98(6):1497-507. PubMed ID: 1278114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of physical exercise on catechol-O-methyltransferase activity in depressive patients: A preliminary communication.
    Carneiro LS; Fonseca AM; Serrão P; Mota MP; Vasconcelos-Raposo J; Vieira-Coelho MA
    J Affect Disord; 2016 Mar; 193():117-22. PubMed ID: 26773917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced imprecision of the radioenzymatic assay of plasma catecholamines by improving the stability of the internal standards.
    Hoffmann JJ; Willemsen JJ; Lenders JW; Benraad TJ
    Clin Chim Acta; 1986 Apr; 156(2):221-5. PubMed ID: 3708863
    [No Abstract]   [Full Text] [Related]  

  • 51. Radioenzymic measurement of norepinephrine, epinephrine, and dopamine: stability, enzymic activity, and sensitivity.
    Saar N; Bachmann AW; Gordon RD
    Clin Chem; 1981 Apr; 27(4):626-8. PubMed ID: 7471434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects.
    Nunes T; Machado R; Rocha JF; Fernandes-Lopes C; Costa R; Torrão L; Loureiro AI; Falcão A; Vaz-da-Silva M; Wright L; Almeida L; Soares-da-Silva P
    Clin Ther; 2009 Oct; 31(10):2258-71. PubMed ID: 19922897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The part played by catechol-O-methyltransferase in the plasma kinetics of 3,4-dihydroxyphenylglycol and 3,4-dihydroxyphenylalanine in the anaesthetized rabbit.
    Friedgen B; Halbrügge T; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):155-61. PubMed ID: 8474536
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erythrocyte catechol-O-methyltransferase activity in a Swedish population.
    Floderus Y; Ross SB; Wetterberg L
    Clin Genet; 1981 May; 19(5):389-92. PubMed ID: 7296928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of a natural mineral-rich water on catechol-O-methyltransferase function.
    Bastos P; Araújo JR; Azevedo I; Martins MJ; Ribeiro L
    Magnes Res; 2014; 27(3):131-41. PubMed ID: 25560240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorphisms of COMT (c.649G>A), MAO-A (c.1460C>T), NET (c.1287G>A) Genes and the Level of Catecholamines, Serotonin in Patients with Parkinson's Disease.
    Florczak-Wyspianska J; Rozycka A; Wolny L; Lianeri M; Kozubski W; Dorszewska J
    DNA Cell Biol; 2017 Jun; 36(6):501-512. PubMed ID: 28418735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemical correlates of hypnoanalgesia in arthritic pain patients.
    Domangue BB; Margolis CG; Lieberman D; Kaji H
    J Clin Psychiatry; 1985 Jun; 46(6):235-8. PubMed ID: 3158643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Free and conjugated plasma catecholamines in patients with congestive heart failure.
    Francis GS; Goldsmith SR; Pierpont G; Cohn JN
    J Lab Clin Med; 1984 Mar; 103(3):393-8. PubMed ID: 6699464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A simplified radiometric assay for plasma norepinephrine and epinephrine.
    Passon PG; Peuler JD
    Anal Biochem; 1973 Feb; 51(2):618-31. PubMed ID: 4349454
    [No Abstract]   [Full Text] [Related]  

  • 60. Catecholamine metabolic pathways and exercise training. Plasma and urine catecholamines, metabolic enzymes, and chromogranin-A.
    Rogers PJ; Tyce GM; Weinshilboum RM; O'Connor DT; Bailey KR; Bove AA
    Circulation; 1991 Dec; 84(6):2346-56. PubMed ID: 1959190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.